申请人:Geuns-Meyer D. Stephanie
公开号:US20070049592A1
公开(公告)日:2007-03-01
The present invention relates to compounds of Formulas I and II,
wherein A
1
, A
2
, B
1
, B
2
, Q, X
1
, X
2
, Y and R
3
are defined herein, synthetic intermediates, and pharmaceutical compositions, comprising such compounds. The compounds and compositions are capable of modulating various protein kinase receptors such as Tie-2 and, therefore, influencing kinase related disease states and conditions. The compounds, for example, are capable of treating cancer caused by unregulated angiogenesis, and inflammation as well as other proliferative disorders.
本发明涉及具有I和II式的化合物,其中在此定义了A1、A2、B1、B2、Q、X1、X2、Y和R3,合成中间体以及包括这些化合物的药物组合物。这些化合物和组合物能够调节各种蛋白激酶受体,如Tie-2,并因此影响激酶相关的疾病状态和病况。例如,这些化合物能够治疗由于未受调控的血管生成引起的癌症,以及炎症和其他增生性疾病。